tradingkey.logo
搜尋

Anbio Biotechnology

NNNN
添加自選
12.700USD
+0.355+2.88%
收盤 07/02, 13:00美東報價延遲15分鐘
557.42M總市值
86.61本益比TTM

關於 Anbio Biotechnology 公司

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology簡介

公司代碼NNNN
公司名稱Anbio Biotechnology
上市日期Feb 19, 2025
CEOLau (Michael)
員工數量27
證券類型Ordinary Share
年結日Feb 19
公司地址Friedrich-Ebert-Anlage 49
城市FRANKFURT AM MAIN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Germany
郵編60308
電話4916096247281
網址https://anbiobiotechnology.com/
公司代碼NNNN
上市日期Feb 19, 2025
CEOLau (Michael)

Anbio Biotechnology公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

常見問題

Anbio Biotechnology的前五大股東是誰?

Anbio Biotechnology的前五大股東如下:Mr. Michael Lau

有多少機構持有Anbio Biotechnology(NNNN)的股份?

截至2026Q1,共有13家機構持有Anbio Biotechnology的股份,合計持有的股份價值約為2.13M,占公司總股份的4.86% 。與2025Q4相比,機構持股有所增加,增幅為2063041.00。